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Abstract
Background: Mycobacteria use inositol in phosphatidylinositol, for anchoring lipoarabinomannan (LAM),
lipomannan (LM) and phosphatidylinosotol mannosides (PIMs) in the cell envelope, and for the production of
mycothiol, which maintains the redox balance of the cell. Inositol is synthesized by conversion of glucose-6-
phosphate to inositol-1-phosphate, followed by dephosphorylation by inositol monophosphate phosphatases
(IMPases) to form myo-inositol. To gain insight into how Mycobacterium tuberculosis synthesises inositol we carried
out genetic analysis of the four IMPase homologues that are present in the Mycobacterium tuberculosis genome.
Results: Mutants lacking either impA (Rv1604)o rsuhB (Rv2701c) were isolated in the absence of exogenous
inositol, and no differences in levels of PIMs, LM, LAM or mycothiol were observed. Mutagenesis of cysQ (Rv2131c)
was initially unsuccessful, but was possible when a porin-like gene of Mycobacterium smegmatis was expressed,
and also by gene switching in the merodiploid strain. In contrast, we could only obtain mutations in impC (Rv3137)
when a second functional copy was provided in trans, even when exogenous inositol was provided. Experiments
to obtain a mutant in the presence of a second copy of impC containing an active-site mutation, in the presence
of porin-like gene of M. smegmatis, or in the absence of inositol 1-phosphate synthase activity, were also
unsuccessful. We showed that all four genes are expressed, although at different levels, and levels of inositol
phosphatase activity did not fall significantly in any of the mutants obtained.
Conclusions: We have shown that neither impA, suhB nor cysQ is solely responsible for inositol synthesis. In
contrast, we show that impC is essential for mycobacterial growth under the conditions we used, and suggest it
may be required in the early stages of mycothiol synthesis.
Background
Mycobacterium tuberculosis is a major global pathogen.
In 2007, approximately 1.7 million deaths were caused
by tuberculosis (TB) and an estimated 9.3 million people
acquired the infection [1]. Patients can usually be cured
through a six month course of a multiple drug regimen
[2]. The efficacy of chemotherapy has however been
compromised by the appearance of multi- and exten-
sively drug resistant strains [3,4]. The search for poten-
tial novel drug targets and the subsequent development
of new antibiotics is therefore urgent. Ideal candidates
would be mycobacterial-specific and include pathways
involved in the biosynthesis of the unusual cell envelope
[5,6]; the target of some existing antibiotics, including
isoniazid, ethionamide, ethambutol and pyrazinamide
[7].
Inositol is a polyol that is not synthesized in most bac-
terial species. However, in the mycobacteria, inositol is
found in lipoarabinomannan (LAM), a lipoglycan that is
present in high levels in the cell envelope. LAM is com-
posed of a mannan backbone with branched arabinosyl
chains. It is anchored in the cell envelope by means of a
phosphatidylinositol (PI) moiety. Other lipoglycans
found in the cell envelope include lipomannan (LM)
and PI mannosides (PIMs). PI-containing molecules
have been demonstrated as essential for growth in the
fast-growing species Mycobacterium smegmatis,a s
mutants lacking PI synthase are not viable [8].
The function of LAM in cell envelope integrity is
unknown, but evidence suggests that it has profound
effects on the host., for example, it stimulates
* Correspondence: movahed@uic.edu
1Department of Pathology and Infectious Diseases, Royal Veterinary College,
Royal College Street, London NW1 0TU, UK
Movahedzadeh et al. BMC Microbiology 2010, 10:50
http://www.biomedcentral.com/1471-2180/10/50
© 2010 Movahedzadeh et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.macrophages to produce TNFa [9], nitric oxide [10],
and matrix metalloproteinases [11]. LAM may therefore
play a major role in the stimulation of an inappropriate
host immune response, leading to the pathology that is
characteristic of TB. LAM also induces transcriptional
activation of HIV-1 [12,13] and may play a role in the
synergy seen between HIV and TB. In addition to these
effects, LAM is a major antigen [14,15]. While some
PIMs are probable precursors of LAM, they may also
have important functions of their own. PI dimannoside
(PIM2), for example, has been implicated as a receptor
for interacting with mammalian cells [16], as a secreted
activator of Toll-like receptor 2 in macrophages leading
to TNFa induction [17], and as an inducer of granu-
loma formation [18].
Inositol is also a constituent of the major mycobacter-
ial thiol, mycothiol (1-D-myo-inosityl-2- [N-acetyl-L-
cysteinyl] amido-2-deoxy-a-D-glucopyranoside) [19,20],
which helps maintain the redox state of the cell and
detoxifies harmful molecules. A mutant of M. smegmatis
that essentially fails to produce mycothiol is viable, but
grows poorly, and is sensitive to H2O2 [20] However, in
M. tuberculosis the mshA and mshC genes, required for
mycothiol biosynthesis, are essential genes [21,22].
Mycothiol may be more important in pathogenic myco-
bacteria as during infection they would be exposed to
reactive oxygen intermediates within the macrophage.
The biosynthesis of inositol normally occurs in two
steps. In the first, glucose-6-phospate is converted to
inositol-1-phosphate (I-1-P) by inositol phosphate
synthase (Ino1). We have shown previously that an ino1
(Rv0046c) mutant of M. tuberculosis is an inositol auxo-
troph, and is severely attenuated in vivo [23]. In the sec-
ond step, the I-1-P is dephosphorylated by an inositol
monophosphate phosphatase (IMPase) to form inositol.
Previously, we identified the M. smegmatis impA gene,
which is predicted to encode an IMPase, and showed
that inactivation of this gene resulted in an altered col-
ony morphology, reduced levels of PI dimannoside
(PIM2), and altered permeability of the cell wall. This
data suggests that impA is partly responsible for inositol
synthesis in this species, presumably compensated by
t h ep r e s e n c eo fo t h e rimp genes [24]. In this paper, we
describe the genetic analysis of four IMPase homologues
of M. tuberculosis. We demonstrate that three, impA,
suhB and cysQ are dispensible, while impC is essential,
even in the presence of exogenous inositol.
Methods
Bacterial strains, plasmids and media
Bacterial strains and plasmids used are shown in Table
1. M. tuberculosis H37Rv (ATCC 25618) was cultured
on Middlebrook 7H10 agar plus 10% (vol/vol) oleic
acid-albumin-dextrose-catalse (OADC) supplement
(Becton Dickinson). Middlebrook 7H9 broth (Difco)
plus 10% (vol/vol) OADC supplement and 0.05% (wt/
vol) Tween 80 was used to grow liquid cultures. Hygro-
mycin (100 μgm l
-1), kanamycin (20 μgm l
-1), gentami-
cin (10 μgm l
-1)a n dX - G a l( 5 - b r o m o - 4 - c h l o r o - 3 -
indolyl-b-D-galactopyranoside) at 50 μgm l
-1,w e r e
added where appropriate. For supplementation with ino-
sitol, a 14% stock (w/v) (0.77 M) of myo-inositol (Sigma)
was prepared and filter-sterilised. E. coli DH5a was used
for all plasmid constructions.
Bioinformatics
Homology searches were carried out using BLASTP ver
2.2.13 [25] The four homologs identified all had e-values
<10
-3, and no other protein match approached signifi-
cance. Prosite database information was obtained at
http://www.expasy.ch/prosite/, using Release 20.56 dated
November 4
th, 2009.
Construction of M. tuberculosis mutants
Targeted mutagenesis was carried out using a two-step
strategy [26] in order to introduce an unmarked muta-
tion without any potential polar effects.
ImpA
Primers tbimpA1 (CTCGACGTACAGGTTGAGC-
TATCC) and tbimpA2 (CTTCACCTGACCGATCGT-
C A G C T C )w e r eu s e dt oa m p l i f yt h eimpA gene and
flanking regions (2,108 bp) from M. tuberculosis H37Rv
using PCR. The resulting 2.1 kb fragment was cloned
into the EcoRV site of pGEM5, producing pIMP50. A
200 bp SphI fragment within impA was removed follow-
ing partial digestion and religated to make pIMP51. The
2,348 bp PvuII fragment of pIMP51 was cloned into
p2NIL, producing pIMP57.
To create a deletion where the majority of impA
was deleted (769 bp deleted from 813 bp), inverse
PCR was performed on pIMP57. Primers tbimpAinv1
(TCGTGCCAGCTGACCAACGAATCCAAGTGCAT)
and tbimpAinv2 (TCGTGCCAGCTGATAGGGGAAC-
CAGAGGACTA) were used, simultaneously creating a
deletion and introducing a PvuII site in the deleted con-
struct. Following the PCR reaction the DNA was digested
with DpnI for 1 h at 37C to destroy the template, then
digested with PvuII and religated to produce pFM74.
Insertion of a PacI gene cassette from pGOAL19 was
cloned at the PacI site of pFM74 producing the final
delivery plasmid pFM75. The PacI cassette carries lacZ
and sacB, which can be used for positive and negative
selection of unmarked mutant colonies, respectively.
SuhB
A 3,534 bp XhoI fragment of cosmid Y5ab was cloned
into the SalI site of plasmid p2NIL to produce pFM33.
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Strains/plasmids Characteristics Source
E. coli DH5a Invitrogen
M. tuberculosis H37Rv wild-type laboratory strain ATCC 25618
FAME1 M. tuberculosis suhBΔ This study
FAME2 M. tuberculosis impAΔ This study
FAME4 M. tuberculosis impCΔ::pFM96 This study
FAME7 M. tuberculosis::pFM54 (impCΔ SCO) This study
FAME9 FAME7 ::pFM96 This study
FAME11 FAME7::pFM123 This study
FAME63 FAME7::FM203 This study
FAME5 M. tuberculosis ino1Δ [23]
FAME12 M. tuberculosis ino1Δ::pFM54 (SCO) This study
FAME35 M. tuberculosis::pFM151 (cysQΔ SCO) This study
FAME43 FAME35::FM164 This study
FAME53 cysQΔ::FM164 This study
FAME87 FAME35::FM203 This study
FAME93 cysQΔ::FM203 This study
FAME 120 M. tuberculosis
cysQΔ:: pUC-Hyg-int
This study
pBluescript II SK+ Stratagene
pGEM5 Promega
pUC-Gm-int pUC-based plasmid with HindIII cassette carrying gm and L5 int [54]
pUC-Hyg-int pUC-based plasmid with HindIII cassette carrying hyg and L5 int [54]
p2NIL gene manipulation vector, kan [26]
pGOAL19 hyg pAg85-lacZ sacB PacI cassette vector [26]
pIMP50 pGEM5::impA This study
pIMP51 pGEM5::impAΔ (SphI 200 bp) This study
pIMP57 p2NIL::impAΔ (SphI 200 bp) This study
pFM74 p2NIL::impAΔ (769 bp) This study
pFM75 pFM74 with PacI cassette of pGOAL19 This study
pFM33 p2NIL::suhB This study
pFM48 pFM33::suhBΔ This study
pFM52 pFM48 with PacI cassette of pGOAL19 This study
pFM31 p2NIL::impC This study
pFM53 pFM31::impCΔ This study
pFM54 pFM53 with PacI cassette of pGOAL19 This study
pFM94 pBluescript SK+::impC (+288 bp upstream) This study
pFM96 pFM94::int gm This study
pFM123 pFM96::impC D86N This study
PMN013 plasmid carrying the M. smegmatis porin gene mspA [44]
pFM203 pMN013::int gm This study
pFM145 p2NIL::cysQ This study
pFM148 pFM145::cysQΔ This study
pFM151 pFM148 with PacI cassette of pGOAL19 This study
pFM160 pBluescript SK+::cysQ (+352 bp upstream) This study
pFM164 pFM160::int gm This study
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gene by inverse PCR on pFM33 using primers tbsuhBΔ1
(TCAGCATGCGTTCGTTGTCAGGTCGTGTC) &
tbsuhBΔ2 (TCAGCATGCGATTCAACGGCCTA
GAGC); this introduced a SphI site in the deleted con-
struct. Following treatment with DpnIa n dSphI, this
was religated to produce pFM48. Insertion of the gene
delivery cassette from pGOAL19 produced the final
delivery plasmid pFM52.
ImpC
A 2,503 bp StuI fragment of cosmid Y3A2 was cloned
into the PmlI site of p2NIL, producing pFM31. A 731
bp deletion was generated in the 783 bp gene by
inverse PCR on pFM31 using primers tbimpCΔ1
(TGCCAGCTGCATTAGATCGTCGTGGCTCA) &
tbimpCΔ2 (TGCCAGCTGGAGGTGCTGACACGG
CTC) to introduce a PvuII site in the deleted construct.
Following treatment with DpnIa n dPvuII, this was reli-
gated to produce pFM53. Insertion of the delivery gene
cassette from pGOAL19 produced the final delivery
plasmid pFM54.
CysQ
Primers tbcysQ1 (CCTGGTCGACCTGTTTCC) and
tbcysQ2 (GCGGCTCTTTGACATCTTGT) were used to
amplify the cysQ gene and flanking regions (2,748 bp)
from M. tuberculosis H37Rv DNA. The product was
cloned into the PmlI site of p2NIL, producing pFM145.
Primers tbcysQΔ1 (AGTCAGGTCGTCCGTCAGATC)
&t b c y s Q Δ2 (TACAACCAACTGGACCCCTAC) were
used to generate a 666 bp deletion in the 804 cysQ gene
by inverse PCR on pFM145. Following treatment with
Klenow polymerase and T4 polynucleotide kinase (Pro-
mega), this product was religated to produce pFM148.
Insertion of the gene delivery cassette from pGOAL19
produced the final delivery plasmid pFM151.
Mutagenesis
Deletion plasmids were constructed as described above.
The delivery plasmids were introduced into M. tubercu-
losis H37Rv or M. tuberculosis H37Rv ino1,a n ds i n g l e
crossovers (SCOs) isolated by selection for blue hyg
R
kan
R colonies. One SCO colony was plated onto 2%
(wt/vol) sucrose-50 μgm l
-1 X-Gal to isolate bacteria
with a second crossover; this will lead to mutant or
wild-type cells depending on the location of the recom-
bination event. In order to screen for impC mutant,
DNA was extracted from sucrose
S kan
S white colonies
(obtained from plating M. tuberculosis FAME9 onto
sucrose medium) and analysed by PCR using primers
that flank the impC gene (TBC1: GGACCGCGATCAG
TATGAGT and TBC2: TCGACACAGAATCCGC
TAGA). Strains carrying the impC wild-type allele
would produce a band of 1148 bp whereas strains carry-
ing an impC mutation would carry the deletion band of
417 bp. Mutant candidates and a wild-type control were
digested with PvuII and subjected to Southern blot ana-
lysis using a 2.5 kb impC probe (impC plus flanking
region). The wild-type strain showed a 4 kb band whilst
the mutant showed a 3.2 kb deletion band along with a
2.5 kb band for the integrated impC copy
Complementation
A construct expressing the impC gene was made by
PCR amplification of the impC gene, together with 288
bp of upstream sequence using chromosomal M. tuber-
culosis H37Rv as template DNA. The primers tbimpC-
BamP (CGCGGATCCGGCGATGGTGACAT) and
tbimpCBam (CGCGGATCCTTACCCGGCGTTGAGC)
were used. The product was digested with BamHI and
cloned into the BamHI site of pBluescript-SK+ to pro-
duce pFM94. The HindIII cassette of pUC-Gm-int, car-
rying the int and gm genes was cloned into the HindIII
site of pFM94 to produce pFM96.
A construct expressing the cysQ gene was made by
PCR amplification of the cysQ gene including 352 bp of
upstream sequence using M. tuberculosis H37Rv; chro-
mosomal template DNA; primers tbcysup (GCATA
GAGCAGGAGGTTTGC) and tbcysend (GCGCCAC
GCGTCGGCGAT) were used. The PCR product was
treated with T4 polynucleotide kinase and cloned into
the SmaI site of pBluescript-SK+ to produce pFM160.
The HindIII cassette of pUC-Gm-int, carrying the int
and gm genes was cloned into the HindIII site of
pFM160 to produce pFM164.
Site-directed mutagenesis
Site-directed mutagenesis was carried out using the
non-PCR-based Quickchange kit (Stratagene). Oligonu-
cleotides D86N-forward (GGATCGTAGACCCGAT
CAACGGCACCAAAAACTTTGTGC) & D86N-reverse
(GCACAAAGTTTTTGGTGCCGTTGATCGGGTCT
ACGATCC) were used to prime DNA synthesis with
pFM96. Sequencing confirmed the presence of the
required mutation.
Real-time quantitative PCR
RNA was prepared from an exponential (7-day) rolling
culture of M. tuberculosis H37Rv [27] and cDNA synth-
esis was carried out using Superscript II (Invitrogen)
according to the manufacturer’s protocol. Primers were
designed for Real-time quantitative PCR (RTq-PCR) for
sigA (endogenous control), impA suhB, impC and cysQ)
using the Primer3 software, ensuring products would be
less than 500 bp (Table 2). RTq-PCR reactions were set
up using the DyNAmo SYBR Green qPCR kit (MJ
Research). RT-qPCR was performed using the DNA
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tation) using a standard 1 × DNA master SYBR Green I
mix, 1 μl cDNA product and 0.3 mM of each primer in
20 μl on ice. The primer concentrations had first been
optimised. Samples were heated to 95°C for 10 min
before cycling for 35 cycles of 95°C for 30 s, 60°C
(impA, suhB, impC and cysQ) or 62°C (sigA)f o r2 0s ,
and 72°C for 20 s. Fluorescence was captured at the end
of each cycle after heating to 80°C to ensure the dena-
turation of primer dimers. In order to measure relative
gene expression levels, standard curves for each primer
set were generated by performing PCR with SYBR green
detection on serial dilutions of quantified genomic
DNA. CT values were converted into the equivalent of
copy number by comparison to the standard curve.
Control reactions where RNA had not been reverse
transcribed were used to confirm that there was no sig-
nificant contaminating genomic DNA present. In order
to control for any differences in reverse transcriptase
efficiencies each value was standardized to sigA to gen-
erate unit-less values. SigA is a major housekeeping gene
and levels of sigA mRNA remains constant under a wide
range of conditions [28]. Two independent RNA sam-
ples were assayed in triplicate for each gene.
Cell wall analysis
Extraction and analysis of PIMs
Cells (0.2 g) were delipidated with chloroform/methanol
(1/1, v/v) for 48 h at room temperature with continuous
stirring. Lipids were separated from the delipidated cells
by centrifugation (3000 rpm, 15 min, 2600 xg)a n da n a -
lysed by TLC on silica gel-coated plates developed with
chloroform/methanol/water (60:35:8, v/v/v). The various
PIMs were identified by their mobilities on TLC and
their positive reactivity compared to authentic standards;
these included a sugar and phospholipid-specific reagent
(0.2% anthrone in concentrated H2SO4 followed by heat-
ing) and the Dittmer-Lester reagent that specifically
detects phosphorous-containing lipids, respectively [29].
Production and analysis of LAM and LM
Delipidated cells were washed and disrupted using a Cell
disrupter (2 kbars, Constant System Ltd; one shot
model). The resulting material was extracted with 40
mL ethanol/water (1/1, v/v) for 8 h at 65°C; the bacterial
residues were discarded and the supernatant was dried.
Six ml hot phenol/water (1/1, v/v) were added and the
mixture was heated for 1 h at 70°C under continuous
stirring, followed by a two-phase partition. The phenol
phase was discarded and the upper phase extensively
washed and dried. The extract was solubilised in water
and Triton X114 (2% wt/v) was added to the cooled sus-
pension. The mixture was stirred for 10 min and then
heated at 50°C until two phases formed. The detergent
phase was recovered, diluted by adding 1 ml water and
washed three times with CHCl3. The resulting aqueous
phase was dried to evaporate the chloroform and resus-
pended in water (0.2 ml). This portion was analysed by
SDS-PAGE with a 5% stacking gel and a 15% running
gel. Samples were denatured in the presence of 2% SDS
in 50 mM Tris-HCl (pH 6.8). After electrophoresis, gels
were treated with periodate/ethanol/acetic acid (0.7/40/
5, w/v/v), and silver-stained. Authentic samples of
mycobacterial LAM and LM from Mycobacterium bovis
BCG were used as standard.
Sugar compositional analysis
The sugar constituents of the various materials were
determined after acid hydrolysis with 2 M CF3COOH at
110°C for 1 h; the mixture of hydrolysed products was
dried, treated with trimethylsilyl reagents [30] to deriva-
tise monosaccharides and analysed by gas chromatogra-
phy (GC) for their sugars.
Gas chromatography and mass spectrometry
GC was performed using a Hewlett Packard HP4890A
equipped with a fused silica capillary column (25 m
length × 0.22 mm i.d.) containing WCOT OV-1 (0.3 mm
film thickness, Spiral). A temperature gradient of
100-290°C at 5°C min-1, followed by a 10-min isotherm
plateau at 290°C, was used.
Mycothiol assay
Labelling of cell extracts with monobromobimane
(mBBr) to determine thiol content was performed with
modifications to previously published protocols [31,32].
Cell pellets from 3 ml culture were resuspended in 0.5
ml of warm 50% acetonitrile-water containing 2 mM
mBBr (Cal Biochem), and 20 mM HEPES-HCl, pH 8.0.
T h es u s p e n s i o nw a si n c u b a t e df o r1 5m i ni na6 0 ° C
water bath and then cooled on ice. A final acidic pH
was produced by adding 2-5 μl5MH C lo r5Mt r i -
fluoracetic acid.
The control samples were extracted with 0.5 ml of
warm 50% acetonitrile-water containing 5 mM N-ethyl-
malemide and 20 mM HEPES-HCl, pH 8.0. The suspen-
sion was incubated for 15 min in a 60°C water bath and
Table 2 Primers used in Real time quantitative PCR
Gene Primer pair Primer sequence
sigA SIGAF ATCTGCTGGAAGCCAACCT
SIGAR GATCACCTCGACCATGTGC
impA IMPAF: CGATCTCGTCTTCGTCGC
IMPAR: CCCTATGCTGCCAAGAATCTC
suhB IMPBF: GCGAGAAGCAGGCAGAATT
IMPBR: CTCTCGGCGTTGACAACAA
impC IMPCF: GCTGCTTGAAGATGGCGTC
IMPCR: CCACCAGGCAGTAAGACAGAA
cysQ CYSQF: ATCTGACGGACGACCTGACT
CYSQR: CCAACGGGTCAATAATCCAC
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solution followed by a second incubation for 15 min in
a 60°C. The control sample was cooled but not acidified.
Cell debris was pelleted in each sample by centrifugation
(5 min 14,000 × g).
HPLC analysis of thiols was carried out by injecting 25
μl of 1:4 dilution of samples in 10 mM HCl on to a
Beckman Ultrasphere IP 5 μ(250 mm × 4.6 mm) col-
umn using 0.25% glacial acetic acid pH 3.6 (buffer A)
and 95% methanol (buffer B). The gradient was: 0 min,
10% B; 15 min, 18% B; 30 min, 27% B; 32 min, 100% B;
34 min, 10% B; and 60 min, 10% B (reinjection). The
flow rate was 1 ml min
-1, and the fluorescence detection
was accomplished on a Varian Fluorichrom model
430020 with a 370 nm excitation filter and a 418-700
nm emission filter. Data collection and analysis was per-
formed on Dynamax Mac Integrator (Rainin
Instruments).
Impase activity
Bacteria were grown to mid-log phase, and collected by
centrifugation. Each pellet was washed once in distilled
water followed by resuspension in 2.5 ml 2 mM dithio-
threitol in 50 mM Tris-Cl, pH8. The suspended bacteria
were disrupted in a FastPrep220A at 4 m/sec for 3 cycles
of 20 sec in Lysing Matrix B (0.1 mm silica beads), with
cooling on ice between cycles. The resulting cell-extracts
were then clarified at 4000 g for 4 min using a bench
centrifuge and filter-sterilised through 0.2 μm pore cellu-
lose acetate filters (Sartorius Minisart). Each clarified cell
extract was desalted through Pharmacia PD-10 columns
according to the manufacturer’s instructions; with the
exception that 3.2 ml (not 3.5 ml) protein fraction was
collected. For equilibrating, desalting and eluting using
PD-10, 50 mM Tris-Cl, pH8 was used.
Phosphatase assays were conducted using 0.4 mM
substrates at 37°C, as described previously [33] although
the reaction volume used was 120 μla n dw a ss t o p p e d
with 30 μl malachite green reagent. No precipitates were
formed so the entire assay was performed in ELISA
plate wells. Inorganic phosphate present in each well
was calculated by reading the OD against a standard
curve. Enzyme activity was then calculated by subtract-
ing the phosphate formed in wells with cell extract and
substrate, from phosphate formed in corresponding
wells with cell extract but without substrate.
Results
Bioinformatics analysis
There are four genes in the M. tuberculosis genome that
encode proteins with significant homology to IMPases.
All four M. tuberculosis proteins are equally distant
from the human IMPase (PDB structure 1IMA; 22-30%
identity, 37-46% similarity) [34] and the aligned amino
acid sequences are shown in Figure 1A. The four
proteins are only as similar to each other, as to the
human protein (27-32% identity, 36-44% similarity).
These four genes are generally conserved in other acti-
nomycete genomes, with for example, apparent ortho-
logs in Mycobacterium avium, Mycobacterium
smegmatis,a n dCorynebacterium glutamicum (data not
shown). M. leprae, which has many pseudogenes, has no
functional impA. Other genomes do also have a small
number of other IMPase genes (thus, M. avium has a
fifth paralog that is similar to cysQ). While levels of
homology between the different M. tuberculosis IMPase
paralogs are moderate (22-30% amino acid identity),
similarities between orthologs are much higher (for
example, 75-79% identity between M. tuberculosis and
M. leprae, and 51-67% identity between M. tuberculosis
and M. smegmatis).
The genomic contexts of these genes are shown in
Figure 2. As with M. smegmatis [24], the impA gene
(Rv1604) lies in the middle of the main his operon
between hisA and hisF. The stop codon of hisA overlaps
with the putative start codon of impA, and the stop
codon of impA overlaps with the putative start codon of
hisF. These impA genes are 70% identical.
The suhB gene (Rv2701c) was named in the original
genome annotation [35], because it is the gene most
similar to the Escherichia coli suhB gene. The E. coli
suhB gene was so-named because deletion of the gene
resulted in a cold-sensitive phenotype, and suppression
of a thermosensitive rpoH mutation [36]. It has also
been shown to suppress secY [37], dnaB [38], and era
[39] mutations. However, these phenotypes are not
related to the enzymatic properties of the protein, as
they are unaffected by a null point mutation in the
active site [40] (Figure 1B). Furthermore, inositol pro-
duction is not believed to occur in E. coli, so the biolo-
gical context is very different from that in mycobacteria.
Recombinant SuhB from M. tuberculosis has been con-
firmed to have IMPase activity [41]. SuhB is monocistro-
nic in M. tuberculosis (Figure 2).
The third homologous gene is Rv3137, which we have
called impC. It appears to be the first gene in a two-
gene operon; a 457 bp intergenic gap upstream of impC
suggests it has its own promoter., and a second gene,
pflA, is predicted to start only 14 bp downstream, so is
probably co-transcribed. PflA shows homology to pyru-
vate formate lyase-activating proteins. Beyond this is a
cluster of fad genes (fadE24-fadE23-fadB4), but the gap
beyond pflA and fadE24 i s7 9b p ,s oi sl e s sl i k e l yt ob e
part of the same operon.
The fourth homologous gene is cysQ (Rv2131c), so-
named because it is most similar to the E. coli cysQ
gene. E. coli cysQ mutants are cysteine auxotrophs dur-
ing aerobic growth [42]. Interestingly M. smegmatis con-
tains two paralogs of this gene.
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Page 6 of 15Figure 1 Alignment of IMPases. The M. tuberculosis H37RvIMPases were aligned using ClustalW. (A) Complete sequences. Motifs shown in bold;
(B) Prosite motifs: ‘*’ identical residues in all sequences; ‘:’ conserved substitutions; ‘.’ semi-conserved substitutions. Sequences were obtained from
http://genolist.pasteur.fr/TubercuList/. Reported Prosite motifs are 1 (N-terminal; PS00629): [FWV]-x(0,1)- [LIVM]-D-P- [LIVM]-D- [SG]- [ST]-x(2)- [FY]-x-
[HKRNSTY]; and 2 (C-terminal; PS00630): [WYV]-D-x- [AC]- [GSA]- [GSAPV]-x- [LIVFACP]- [LIVM]- [LIVAC]-x(3)- [GH]- [GA]. Residues that are not
encompassed by these motifs are in bold italics. Arrows indicate putative metal binding aspartate and isoleucine residues reported for human
IMPase [55]. The underlined residue shows the aspartate mutated in this study, which is equivalent to mutations introduced into the E. coli and
human proteins (see main text).
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Page 7 of 15Two sequence motifs have been described for IMPases
in the Prosite database [43] (see legend to Figure 1B).
One motif, near the N-terminus contains the metal-
binding aspartate residues of the active site, and the
other lies near the C-terminus. All of the gene products
except SuhB had small differences from at least one of
the two IMPase motifs (Figure 1B). However, they all
contain the important metal-binding residues in both
motifs.
The M. tuberculosis impA and suhB genes are dispensable
The impA gene has previously been shown to play an
indirect role in inositol synthesis in M. smegmatis [24],
and a knockout plasmid construct was therefore pre-
pared to isolate an M. tuberculosis impA mutant. As the
gene lies within the his operon (Figure 2), this plasmid
carried an unmarked deletion that would not have polar
effects. The mutant was generated using a two-step
method [26], and grew well on solid medium. Unlike
the M. smegmatis impA mutant which had altered col-
ony morphology, there were no obvious differences in
colony morphology between the wild-type and mutant
strains.
We carried out a similar experiment to determine
whether suhB plays a role in inositol metabolism. Again,
a deletion construct was prepared, and an unmarked
mutant isolated, with no obvious differences in colony
morphology.
Inactivation of CysQ
We constructed a plasmid to delete the cysQ gene. Initi-
a l l y ,w ew e r eu n a b l et oo b t a i nam u t a n t ;o f9 7d o u b l e
crossovers (DCOs) screened in the presence of inositol,
all were wild-type. We therefore made a merodiploid
strain by integrating a second copy of cysQ into the sin-
gle crossover (SCO) strain, and repeating the selection
for DCOs on sucrose. Using this method, 24 out of 30
colonies were found to be mutants. The ability to isolate
a mutant only in the presence of a functional copy of
the gene indicates that this gene was essential under the
conditions tested. It could be inferred that cysQ synthe-
sizes all the inositol in the cell, or all the inositol for a
specific essential molecule. However, this hypothesis is
improbable, as, if true, we would predict thatmutants
would be inositol auxotrophs, yet no mutants were iso-
lated even in the presence of high levels of inositol. One
possibility is that inositol does not penetrate the cell
wall, which is known to be highly impermeable. How-
ever, as we had successfully isolated a mutant lacking
inositol-1-phosphate synthase (an inositol auxotroph),
only when the media was supplemented with extremely
high levels of exogenous inositol (50-77 mM) [23], it
seems that inositol does enter the cell in sufficient quan-
tities but permeability to this molecule is poor. This
suggests that even a slight increase in the requirement
for inositol might make mutant isolation impossible,
since we had reached the limits of inositol solubility.
Figure 2 Genomic context of M. tuberculosis IMPase genes. White arrows: imp genes; black arrows: other genes; open rectangles deleted
regions in knock out plasmids.
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Page 8 of 15We reasoned that an increase in the availability of inosi-
tol by introduction of a porin might allow a mutant to
be isolated. We therefore electroporated an integrating
plasmid (pMN013) carrying the M. smegmatis porin
gene mspA [44,45] (for which M. tuberculosis has no
orthologue) into the SCO strains, and repeated the
sucrose selection. Using this method, we successfully
isolated a cysQ mutant in the presence of 77 mM inosi-
tol. We screened 16 DCO colonies and two were
mutants.
We then plated the mutant on inositol-free medium,
and were surprised to observe normal growth, indicating
that once the mutant has been isolated, it does not
require inositol. To determine whether the mutant could
survive in the absence of the mspA gene, the integrating
plasmid containing this gene was switched with an empty
integrative plasmid carrying the hygromycin resistance
gene (pUC-Hyg-int). This would result in the replace-
ment of the cysQ-carrying plasmid, leaving a stain with
no functional cysQ. Surprisingly, we were able to obtain
cysQ mutants using this approach although we had failed
to isolate a mutant by our standard mutagenesis proce-
dure. We therefore conclude that cysQ is also dispensible,
and a cysQ mutant does not require inositol for growth.
The impC gene is essential
We attempted to construct an unmarked impC deletion
mutant. The first step of the mutagenesis to produce
SCOs worked well, however, when cells carrying a sec-
ond crossover were isolated, only wild-type bacteria
were obtained. In theory, the second crossover could
take place on either side of the deletion, resulting in
either mutant or wild-type cells. The fact that we
obtained only wild-type cells (n = 48) suggested that the
mutants are not viable.
These initial mutagenesis experiments were carried
out in the absence of exogenous inositol. We therefore
repeated the mutagenesis, including different levels of
inositol in the media at all times. Again, only wild-type
bacteria were isolated following the second cross-over
(n= 97; 16 on 15 mM inositol, 8 on 30 mM, 16 on 46
mMl, and 57 on 77 mM).
The inability to obtain a mutant may be due to other
factors, such as a low frequency of recombination on
one side of the gene, even though the length of flanking
D N As h o u l db es u f f i c i e n t( 8 4 7a n d8 7 4b p ) .T h e r e f o r e
we constructed a merodiploid strain by inserting a sec-
ond functional copy of impC into the SCO strain. This
extra copy was present on an L5-based integrating vec-
tor, and contained 288 bp upstream of impC, which was
likely to carry its promoter. When this strain (FAME9)
was plated onto sucrose to isolate DCOs, three out of
eight colonies isolated had lost the original copy of
impC. The fact that this gene could only be lost when a
second copy of the gene is present suggests that impC is
essential for survival, even in the presence of high levels
of exogenous inositol (Fisher’s exact test, p < 0.01, com-
paring only the experiments with 77 mM inositol and
the complemented strain). To further investigate the
essentiality of the impC gene, and in view of what was
observed with cysQ,w ei n t r o d u c e dt h emspA gene into
the impC SCO strain; this time we were not successful
in obtaining a mutant, indicating that the difficulty we
encountered making an impC mutant differed from
cysQ.
A difference between an IMPase mutant and an ino1
mutant may be that inositol-1-phosphate accumulates in
the IMPase mutant, which might somehow be detrimen-
tal to the cell. We therefore carried out the essentiality
experiment in an ino1 mutant background. The impC
mutant construct was introduced into M. tuberculosis
ino1, and a SCO strain isolated. On plating for DCOs,
only wild-type colonies were isolated (n = 38), again
suggesting that this was not the explanation for the
essentiality.
Site directed mutagenesis of impC
Our results suggest that impC does not have a critical
role in inositol production and hence our inability to
obtain an impC mutant may indicate that impC has a
different or secondary function that prevents isolation of
a mutant. For example, the enzyme might form part of
an enzyme complex, and play a vital structural role in
maintaining the integrity of that complex. Deletion of
the gene would then have both enzymatic and structural
effects. An analogous situation was found with the E.
coli SuhB protein; where phenotypes in suhB mutants
were not related to IMPase activity, as a point mutation
in the active site did not produce the suppressing phe-
notype [40]. We therefore used the same approach to
try to separate enzymatic activity from a structural role.
AD 9 3 Nc h a n g ei nE. coli SuhB and an equivalent
D90N change in the human IMPase suppress activity
[40,46] (Figure 1B). Site-directed mutagenesis was used
to introduce a corresponding mutation (D86N) in the
M. tuberculosis impC gene using the integrating plasmid
pFM96 previously used for complementation. This plas-
mid (pFM123) was introduced into the SCO strain
FAME7, and the resultant strain (FAME11) was streaked
onto sucrose/inositol plates. DCO colonies were ana-
lysed, and, in contrast to the situation with pFM96, all
were shown to be wild-type (n = 52). The fact that the
functional impC gene could not be replaced by this
mutated gene, even in the presence of inositol (p <
0.01), shows that the mutation did inactivate enzymatic
activity, and (assuming that the structure was not
affected) that it is this enzymatic activity that is essen-
tial, rather than an additional structural role.
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Page 9 of 15Enzyme activities
In order to gain a greater understanding of the function
of these IMPases, we expressed impC as a recombinant
protein. However, despite using different plasmid con-
structs and strategies, we were unable to obtain a solu-
ble protein (not shown). As an alternative to directly
assaying enzyme activity, we assayed IMPase activity in
cell extracts of the mutant strains to obtain information
about their relative contributions to inositol synthesis.
We compared enzyme activities in whole cell extracts
from the wild-type and mutant strains (Tables 3 and 4).
Of the seven substrates tested, phosphate release as a
r e s u l to fa d d i n gt h ee n z y m es o u r c ew a ss i g n i f i c a n t l y
higher than controls for fructose bisphosphate (FBP),
the inositol phosphates, 5’ AMP and p-nitrophenyl-
phosphate. Deletion of the impA, suhB,o rcysQ genes
made no significant difference to IMPase activity. The
cysQ mutants had significantly less FBPase than the par-
ent strain, (P < 0.05; t-test). However, the fructose
FBPase activity in the H37Rv control for the cysQ
mutants (Table 4) is significantly less than in H37Rv
control used for impA and suhB mutants (P < 0.05; t-
t e s t )( T a b l e3 )s u g g e s t i n gt h a t the small but significant
differences reported in this study may be due to batch-
to-batch variation rather than in relation to any
mutations.
PIM, LAM and mycothiol levels are normal in the impA,
suhB and cysQ mutants
Cell extracts of the mutant strains were prepared for
the assay of inositol-containing molecules (cell envelope
glycolipids and mycothiol). TLC analyses showed that
PIMs were normal in the mutant strains (Figure 3A),
whilst polyacrylamide gel electrophoresis (Figure 3B)
and sugar compositional analysis (not shown) demon-
strated normal levels of LAM and LM. Mycothiol levels
were assayed by HPLC analysis; levels in the impA,
suhB and cysQ mutants were similar to wild-type (see
Figure 4).
Gene expression levels of imp genes in M. tuberculosis
The relative contributions of the IMPase homologues will
be proportional to their activity, and their level of expres-
sion. We therefore carried out RTq-PCR experiments to
determine the levels of expression of impA, suhB, cysQ
and impC mRNA in exponential cultures of M. tubercu-
losis. Expression levels were normalized to those of sigA
mRNA which remains constant. The level of cysQ was
the highest, almost equal to sigA (Table 5). impA and
impC were expressed at approximately 40% of this level,
while suhB was lowest, at 12% of the cysQ level.
Discussion
To investigate how M. tuberculosis synthesises inositol,
we carried out a genetic analysis of four IMPase homolo-
gues in M. tuberculosis.T h eimpA and suhB genes were
shown to be dispensable, with no phenotype detected in
terms of the levels of mycothiol, PIMs, LM or LAM.
CysQ is also dispensible, although isolating the mutant
proved more difficult, requiring introduction of the M.
smegmatis mspA porin gene for mutant isolation, but not
for subsequent survival. It cannot be excluded, however,
that the cysQ mutants that were eventually obtained had
acquired a suppressor mutation, which had allowed dele-
tion of cysQ or had allowed growth of the mutant on
media lacking inositol and preventing cell death. In con-
trast to these three genes, we were only able to inactivate
impC by introducing a second copy of the gene. The
TraSH mutagenesis protocol which provides a genome-
wide indication of essentiality [47] supports our data,
with only impC of these four genes being reported as
putatively required for optimal growth in vitro.
Inositol production is likely to be essential for myco-
bacterial growth, because of the essentiality of both
classes of mycobacterial inositol-containing molecules,
namely phospholipids [8] and mycothiol Our previous
work showing that a PI synthase mutant is an inositol
auxotroph [23] is consistent with this. Both SuhB and
CysQ have been shown to have IMPase activity [41,48]
Table 3 Phosphatases in cell extracts of impA, suhB
mutants
Substrate H37Rv ΔimpA ΔsuhB
Fructose-1,6-bisP 26.04 ± 1.85 (5) 28.18 ± 0.92 (5) 32.70 ± 0.44 (5)
Inositol-1-P 0.63 ± 0.13 (6) 0.79 ± 0.12 (5) 0.63 ± 0.25 (6)
Inositol-2-P 1.20 ± 0.15 (4) 1.33 ± 0.22 (5) 1.03 ± 0.15 (6)
Glycerol-2-P 0.08 ± 0.06 (12) -0.02 ± 0.03 (2) 0.39 ± 0.03 (2)
Glycerol-3-P -0.13 ± 0.12 (12) -0.08 ± 0.03 (2) 0 ± 0.21 (2)
5’ AMP 4.22 ± 0.36 (8) 4.13 ± 0.40 (2) 5.74 ± 0.04 (2)
p-nitrophenyl-P 3.00 ± 0.35 (12) 3.55 ± 0.14 (2) 4.38 ± 0.36 (2)
Values: nmol/min/mg protein, mean ± SEM (n). Differences between levels in
mutants and the parent strain were not significant (P > 0.05; t-test).
Table 4 Phosphatases in cell extracts of the cysQ mutants
Substrate H37Rv ΔcysQ 203/12 ΔcysQ203/16
Fructose-1,6-bisP 18.94 ± 1.00 (6) 13.09 ± 1.24 (6) 12.41 ± 0.54 (7)
Inositol-1-P 0.40 ± 0.09 (8) 0.49 ± 0.17 (9) 0.57 ± 0.16 (9)
Inositol-2-P 0.84 ± 0.12 (8) 0.90 ± 0.27 (10) 0.70 ± 0.23 (10)
Glycerol-2-P 0.75 ± 0.32 (8) 1.02 ± 0.27 (10) 0.55 ± 0.15 (10)
Glycerol-3-P -0.37 ± 0.28 (3) -0.35 ± 0.14 (3) 0.27 ± 0.45 (3)
5’ AMP 1.42 ± 0.31 (3) 1.69 ± 0.14 (3) 1.39 ± 0.03 (3)
p-nitrophenyl-P 5.51 ± 0.36 (2) 3.64 ± 1.92 (2) 2.83 ± 0.25 (3)
Values: nmol/min/mg protein, mean ± SEM (n). Level of FBPase in cysQ
mutants relative to parent strain is significantly different (P < 0.05; t-test).
Level of FBPase in H37Rv parent strain reported in table 4 is significantly
different (P < 0.05; t-test) to that reported in Table 3.
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Page 10 of 15a n dw eh a v es h o w nt h a tt h eM. smegmatis ImpA has
IMPase activity (unpublished data). However, none of
the three mutants constructed are auxotrophic for inosi-
tol, indicating that there is potential redundancy of
function between the homologs and deletion of three or
four genes might be required to see sufficient loss of
activity to cause auxotrophy. A recent report suggests
that CysQ is likely to play a role in sulphur metabolism,
as its activity as 3’-phosphoadenosine-5’-phosphatase is
several orders of magnitude higher than as an inositol
phosphatase [49]. However, it may still contribute to the
redundancy in inositol phosphatase activity.
To determine the potential relative contribution of
each of these genes to inositol synthesis we carried out
two experiments. One experiment looked at the relative
amounts of mRNA using real-time RTq-PCR. All
mRNA species were detectable, with cysQ being most
abundant (approximately the same level as sigA,t h e
Figure 3 Analyses of cell wall major constituents of some representative mutants; the other strains exhibited profiles similar to those
shown. (A) TLC analysis of extractable lipids. (B) SDS-PAGE of lipopolysaccharides. WT: M. tuberculosis H37Rv; ΔA: impA mutant; ΔB: suhB mutant;
S: authentic standard of mycobacterial LAM and M. bovis BCG LM; TMM: trehalose monomycolate; PE: phosphatidylglycerol; PG:
phosphatidylethanolamine; LAM: lipoarabinomannan; LM: lipomannan; PIM: phosphatidylinositol mannoside.
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Page 11 of 15major housekeeping sigma factor), and impA being the
least abundant, with a level only one-tenth that of cysQ.
We also assayed the level of IMPase activity in the
whole cell extracts of each mutant, reasoning that we
m i g h ts e ead e c r e a s ei na c t i v i t yw h e no n eo ft h eg e n e s
was deleted. However, no decrease in activity was
observed in any of the three mutants compared to the
wild-type strain. This could be a reflection on the sensi-
tivity of our assay, or could indicate that the activity is
regulated (either at the transcriptional or post-transcrip-
tional level) such that a constant level is maintained.
We also have preliminary data that expression of the
impC gene is regulatable. We grew a Δino1 mutant of
M. tuberculosis (which needs >50 mM inositol for its
normal growth [23]) and looked at the effect of removal
of the inositol on gene expression. The only IMPase
gene with changed expression was impC,w h i c hw a s3 -
fold increased. We cannot link this change directly to
the inositol, because it could also be caused by the
change in osmolarity, but at the very least indicates this
indicates this gene is regulatable (unpublished results).
The situation with impC is complicated in that we
could neither obtain a mutant, nor do we have biochem-
ical evidence that it functions as an IMPase (despite
many attempts to achieve both). The essentiality cannot
b eas i m p l ec a s eo fimpC producing the majority of the
inositol in the cell, as we added inositol exogenously. It
is true that the ino1 mutant we made previously, which
is an inositol auxotroph, required levels of inositol
approaching the maximum solubility limit, so a require-
ment for a slightly increased level of inositol might
explain our findings. However, this is unlikely because
(i) we also introduced a porin gene to increase inositol
uptake, with no effect, (ii) we would also have to explain
why the other three IMPase genes are not sufficient,
and (iii) the level of impC mRNA is only 21% of the
total IMPase mRNA (41% if cysQ is excluded). The only
pieces of evidence we have, therefore, that link impC to
inositol production are (i) its clear homology to
IMPases, and (ii) the circumstantial evidence that levels
of impC increased in a microarray experiment where
inositol was removed from an ino1 auxotroph, whereas
the expression level of the other IMPase genes was not
significantly changed. We recognise the difficulty of car-
rying out the latter experiment in a controlled way since
removing such a high level of inositol from the medium
could have other effects. Interestingly, impC was also
upregulated in the Wayne low oxygen model, particu-
larly when M. tuberculosis cultures entered a microaero-
philic state known as nonreplicating persistent stage 1
(NRP1), where there is cessation of bacterial replication,
strong induction of respiratory nitrate reductase activity,
and a change in energy metabolism (3.3-fold induced)
[50].
Figure 4 HPLC analysis of mycothiol (marked with an arrow) in
representative mutants; the other strains exhibited profiles similar
to those shown. WT: M. tuberculosis H37Rv; ΔA: impA mutant; ΔB:
suhB mutant. Free thiol peaks are marked as standard (lower panel)
MS-mB marks the mycothiol peak and and Ac-Cys-mb represent an
Acetyl-Cysteine thiol.
Table 5 mRNA levels
Gene mRNA level normalised to sigA*
impA 0.41 (0.3- 0.5)
suhB 0.11 (0.096- 0.13)
impC 0.36 (0.27- 0.46)
cysQ 0.95 (0.76- 1.18)
*To ensure equal amounts of cDNA were used each value was standardized
to sig A to generate unit-less values
(95% confidence interval)
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Page 12 of 15We tested the hypothesis that the essentiality of impC
is unrelated to its enzymatic activity by constructing a
site-directed mutation. The mutation introduced
changes at an active-site of glutamate to glutamine; the
analogous mutation has been shown to abrogate activity
in the human protein [40,46]. Our inability to isolate
mutants, strongly suggests that (i) the point mutation
does indeed affect the activity of the enzyme and (ii)
impC carrying this point mutation cannot complement
a null mutant even in the presence of inositol. These
findings oppose our hypothesis of a structural role for
ImpC, and support an enzymatic role, as an explanation
of its essentiality. There still remains a possibility that
the mutation also affects th es t r u c t u r ea sw eh a v en o t
shown that folded protein is still produced, but we
b e l i e v et h i si su n l i k e l yg i v e nt h es u b t l en a t u r eo ft h e
change introduced. Another possible explanation for the
inositol-independent essentiality is that removal of
ImpC results in a build up of inositol-1-phosphate,
which is somehow deleterious to the cell. However, we
were unable to obtain an impC mutant in an ino1 back-
ground. It is feasible that ImpC uses a substrate other
than inositol i.e. one involved in mycothiol production.
The elegant work of Fahey and co-workers has defined
most of the mycothiol biosynthesis pathway, but is miss-
ing a predicted phosphatase., which dephosphorylates
N-acetyl glucosamine-(a1,3)-1L-inositol-1-phosphate.
We carried out preliminary experiments attempting to
make an impC mutant using this substrate (kindly pro-
vided by R. Fahey and G. Newton), without success (not
s h o w n ) .H o w e v e r ,w eh a v en oe v i d e n c et h a ti tw o u l d
p e n e t r a t et h ec e l l ,s ow ef e e lw ec a n n o td r a wa n y
conclusions.
The impC gene lies upstream of the pflA gene and
may be co-transcribed, as the intergenic gap is only 19
bp. PflA shows homology to pyruvate formate lyase-acti-
vating proteins; oxygen-sensitive iron-sulfur proteins
that activate an anaerobic ribonucleotide reductase in
some bacteria [51], although there does not appear to
be a homologue to E. coli pyruvate formate lyase in the
M. tuberculosis genome. We designed an unmarked
deletion of impC, in order to prevent polar effects. In
addition, complementation with impC alone was suffi-
cient to allow mutants to be isolated. We have therefore
excluded polar effects on pflA as an explanation for the
essentiality.
The Mycobacterium leprae genome contains many
pseudogenes therefore genomic comparisons may give
an indication as to which mycobacterial genes are essen-
tial. In M. leprae,t h eimpA orthologous gene is a pseu-
dogene, with several frameshifts in the distal half of the
gene, whereas the other three orthologous IMPase genes
are retained. The suhB orthologous gene (ML1024)
appears to be functional, and has a similar genomic
context to the M. tuberculosis gene. The orthologous
impC gene (ML0662) appears to be monocistronic in
this species, and the orthologous cysQ gene (ML1301)i s
also present. The lack of phenotype in an M. tuberculo-
sis impA mutant contrasts with the situation seen in M.
smegmatis,w h e r ea nimpA mutant had altered colony
morphology, slower growth, and reduced levels of PIM2
[24]. The fact that the M. smegmatis mutant is viable
supports the idea of some redundancy of function, and
we suggest that the differences in phenotype are caused
by different levels of ImpA compared to other IMPases
in the two species.
Given that inositol monophosphatase and fructose-
bisphosphatase activities were detected in cell extracts
from impA, suhB and cysQ mutants, none of these
genes can encode the major enzyme for these activities.
The cysQ gene product does in fact act as a phosphatase
with fructose-1,6- bisphosphate and inositol-1-phosphate
[48], but enzyme activity in assays does not always
equate to functionality in living bacteria. An example is
found in Thermococcus kodakarensis where knocking
out the fbp gene encoding a fructose bisphosphatase
with high substrate specificity resulted in a strain unable
to grow on gluconeogenic substrates whilst knocking
out its imp gene encoding a member of the carbohy-
drate phosphate superfamily with substrate specificity
including fructose-1,6- bisphosphate did not affect its
growth on any carbon sources [52]. In M. tuberculosis,
the effect of knocking out the glpX gene that encodes
fructose bisphosphatase is so drastic it is difficult to
envisage that impA, suhB or cysQ can compensate for
its loss [53].
Conclusions
We have demonstrated that the M. tuberculosis impA,
suhB and cysQ genes are dispensable, but that impC is
essential under the growth conditions used. The reason
for the essentiality is unclear in terms of inositol synth-
esis; at present the most attractive hypothesis is that
impC is required for mycothiol synthesis.
Acknowledgements
We thank Jane Turner for excellent technical assistance; Bob Cox for the
suggestion to use mspA, Gerry Newton, Bob Fahey, Anne Lemassu, Philip
Draper and Del Besra for helpful discussions, and Michael Niederweis and
Claudia Mailaender for plasmid pMN013. FM was funded by the Wellcome
Trust (project grant 051880) and the European Union TB vaccine cluster
Contract no. QLK2-1999-01093 and Wellcome Trust grant 073237. PRW was
funded by the Department for Environment, Food & Rural Affairs (UK), and
(DEFRA). M. tuberculosis cosmids were kindly provided by Carol Churcher at
the Sanger Centre.
Author details
1Department of Pathology and Infectious Diseases, Royal Veterinary College,
Royal College Street, London NW1 0TU, UK.
2Tuberculosis Research,
Veterinary Laboratories Agency, New Haw, Addlestone, Surrey KT15 3NB, UK.
3CNRS, Institut de Pharmacologie et Biologie Structurale, UMR CNRS-
Movahedzadeh et al. BMC Microbiology 2010, 10:50
http://www.biomedcentral.com/1471-2180/10/50
Page 13 of 15Université Paul Sabatier (UMR 5089), 205, route de Narbonne, 31077
Toulouse cedex 04, France.
4Department of Medicine, Division of Infectious
Diseases, University of British Columbia, 2733 Heather St., Vancouver, British
Columbia, Canada V5Z 3J5.
5Queen Mary University of London, Barts and the
London School of Medicine and Dentistry, 4 Newark Street, London E1 2AT,
UK.
6Current address: Institute for Tuberculosis Research (M/C 964), College
of Pharmacy, Rm 412, University of Illinois at Chicago, 833 S. Wood St.
Chicago, Illinois USA 60612-7231.
Authors’ contributions
FM carried out the molecular genetic studies, participated in the design and
coordination of the study and drafted the manuscript. PW conceived of the
study, carried out the enzyme assays and wrote the corresponding section
of the manuscript. PD performed cell wall analysis. MD designed the cell
wall analysis and aided in drafting the manuscript. YA conceived of the
study, designed and carried out the Mycothiol assay. TP conceived of the
study, participated in the design and coordination, and aided in drafting the
manuscript. NS conceived of the study, participated in its design and
coordination, performed the bioinformatics and participated in drafting the
manuscript. All authors read and approved the final manuscript.
Received: 8 April 2009
Accepted: 18 February 2010 Published: 18 February 2010
References
1. WHO:http://www.who.int/tb/publications/global_report/2009/pdf/full_report.
pdf.
2. Dye C, Garnett GP, Sleeman K, Williams BG: Prospects for worldwide
tuberculosis control under the WHO DOTS strategy. Directly observed
short-course therapy. Lancet 1998, 352(9144):1886-1891.
3. Espinal MA, Laszlo A, Simonsen L, Boulahbal F, Kim SJ, Reniero A, Hoffner S,
Rieder HL, Binkin N, Dye C, et al: Global trends in resistance to
antituberculosis drugs. World Health Organization-International Union
against Tuberculosis and Lung Disease Working Group on Anti-
Tuberculosis Drug Resistance Surveillance. N Engl J Med 2001,
344(17):1294-1303.
4. Van Rie A, Enarson D: XDR tuberculosis: an indicator of public-health
negligence. Lancet 2006, 368(9547):1554-1556.
5. Daffe M, Draper P: The envelope layers of mycobacteria with reference
to their pathogenicity. Adv Microb Physiol 1998, 39:131-203.
6. Lee RE, Brennan PJ, Besra GS: Mycobacteriumtuberculosis cell envelope.
Curr Top Microbiol Immunol 1996, 215:1-27.
7. Zhang Y, Telenti A: Genetics of drug resistance in Mycobacterium
tuberculosis. Molecular genetics of mycobacteria Washington, D.C.: ASM
PressHatfull GF, Jacobs WR Jr 2000, 235-254.
8. Jackson M, Crick DC, Brennan PJ: Phosphatidylinositol is an essential
phospholipid of mycobacteria. J Biol Chem 2000, 275(39):30092-30099.
9. Moreno C, Taverne J, Mehlert A, Bate CA, Brealey RJ, Meager A, Rook GA,
Playfair JH: Lipoarabinomannan from Mycobacterium tuberculosis induces
the production of tumour necrosis factor from human and murine
macrophages. Clin Exp Immunol 1989, 76(2):240-245.
10. Chan ED, Morris KR, Belisle JT, Hill P, Remigio LK, Brennan PJ, Riches DW:
Induction of inducible nitric oxide synthase-NO* by lipoarabinomannan
of Mycobacterium tuberculosis is mediated by MEK1-ERK, MKK7-JNK, and
NF-kappaB signaling pathways. Infect Immun 2001, 69(4):2001-2010.
11. Chang JC, Wysocki A, Tchou-Wong KM, Moskowitz N, Zhang Y, Rom WN:
Effect of Mycobacterium tuberculosis and its components on
macrophages and the release of matrix metalloproteinases. Thorax 1996,
51(3):306-311.
12. Zhang Y, Nakata K, Weiden M, Rom WN: Mycobacterium tuberculosis
enhances human immunodeficiency virus-1 replication by
transcriptional activation at the long terminal repeat. J Clin Invest 1995,
95(5):2324-2331.
13. Bernier R, Barbeau B, Olivier M, Tremblay MJ: Mycobacterium tuberculosis
mannose-capped lipoarabinomannan can induce NF-kappaB-dependent
activation of human immunodeficiency virus type 1 long terminal
repeat in T cells. J Gen Virol 1998, 79(Pt 6):1353-1361.
14. Da Costa CT, Khanolkar-Young S, Elliott AM, Wasunna KM, McAdam KP:
Immunoglobulin G subclass responses to mycobacterial
lipoarabinomannan in HIV-infected and non-infected patients with
tuberculosis. Clin Exp Immunol 1993, 91(1):25-29.
15. Del Prete R, Picca V, Mosca A, D’Alagni M, Miragliotta G: Detection of anti-
lipoarabinomannan antibodies for the diagnosis of active tuberculosis.
Int J Tuberc Lung Dis 1998, 2(2):160-163.
16. Hoppe HC, de Wet BJ, Cywes C, Daffe M, Ehlers MR: Identification of
phosphatidylinositol mannoside as a mycobacterial adhesin mediating
both direct and opsonic binding to nonphagocytic mammalian cells.
Infect Immun 1997, 65(9):3896-3905.
17. Jones BW, Means TK, Heldwein KA, Keen MA, Hill PJ, Belisle JT, Fenton MJ:
Different Toll-like receptor agonists induce distinct macrophage
responses. J Leukoc Biol 2001, 69(6):1036-1044.
18. Gilleron M, Ronet C, Mempel M, Monsarrat B, Gachelin G, Puzo G: Acylation
state of the phosphatidylinositol mannosides from Mycobacterium bovis
bacillus Calmette Guerin and ability to induce granuloma and recruit
natural killer T cells. J Biol Chem 2001, 276(37):34896-34904.
19. Spies HS, Steenkamp DJ: Thiols of intracellularpathogens. Identification of
ovothiol A in Leishmaniadonovani and structural analysis of a novel thiol
from Mycobacterium bovis. Eur J Biochem 1994, 224(1):203-213.
20. Newton GL, Bewley CA, Dwyer TJ, Horn R, Aharonowitz Y, Cohen G,
Davies J, Faulkner DJ, Fahey RC: The structure of U17 isolated from
Streptomyces clavuligerus and its properties as an antioxidant thiol. Eur J
Biochem 1995, 230(2):821-825.
21. Buchmeier N, Fahey RC: The mshA gene encoding the glycosyltransferase
of mycothiol biosynthesis is essential in Mycobacterium tuberculosis
Erdman. FEMS Microbiol Lett 2006, 264(1):74-79.
22. Sareen D, Newton GL, Fahey RC, Buchmeier NA: Mycothiol is essential for
growth of Mycobacterium tuberculosis Erdman. J Bacteriol 2003,
185(22):6736-6740.
23. Movahedzadeh F, Smith DA, Norman RA, Dinadayala P, Murray-Rust J,
Russell DG, Kendall SL, Rison SC, McAlister MS, Bancroft GJ, et al: The
Mycobacterium tuberculosis ino1 gene is essential for growth and
virulence. Mol Microbiol 2004, 51(4):1003-1014.
24. Parish T, Liu J, Nikaido H, Stoker NG: A Mycobacterium smegmatis mutant
with a defective inositol monophosphate phosphatase gene homolog
has altered cell envelope permeability. J Bacteriol 1997,
179(24):7827-7833.
25. Altschul SF, Madden TL, Schaffer AA, Zhang J, Zhang Z, Miller W,
Lipman DJ: Gapped BLAST and PSI-BLAST: a new generation of protein
database search programs. Nucleic Acids Res 1997, 25(17):3389-3402.
26. Parish T, Stoker NG: Use of a flexible cassette method to generate a
double unmarked Mycobacterium tuberculosis tlyA plcABC mutant by
gene replacement. Microbiology 2000, 146(Pt 8):1969-1975.
27. Betts JC, Lukey PT, Robb LC, McAdam RA, Duncan K: Evaluation of a
nutrient starvation model of Mycobacterium tuberculosis persistence by
gene and protein expression profiling. Mol Microbiol 2002, 43(3):717-731.
28. Manganelli R, Dubnau E, Tyagi S, Kramer FR, Smith I: Differential expression
of 10 sigma factor genes in Mycobacterium tuberculosis. Mol Microbiol
1999, 31(2):715-724.
29. Dittmer JCF, Lester RL: A simple specific spray for the detection of
phospholipids on thin layer chromatography. Journal of Lipid Research
1964, 5:126-127.
30. Sweeley CC, Bentley R, Makita M, Wells WW: Gas-liquid chromatography of
trimethylsilyl derivatives of sugars and related substances. J Am Chem
Soc 1963, 85:2497-2507.
31. Anderberg SJ, Newton GL, Fahey RC: Mycothiol biosynthesis and
metabolism. Cellular levels of potential intermediates in the biosynthesis
and degradation of mycothiol in mycobacterium smegmatis. J Biol Chem
1998, 273(46):30391-30397.
32. Newton GL, Arnold K, Price MS, Sherrill C, Delcardayre SB, Aharonowitz Y,
Cohen G, Davies J, Fahey RC, Davis C: Distribution of thiols in
microorganisms: mycothiol is a major thiol in most actinomycetes. J
Bacteriol 1996, 178(7):1990-1995.
33. Nigou J, Besra GS: Characterization and regulation of inositol
monophosphatase activity in Mycobacterium smegmatis. Biochem J 2002,
361(Pt 2):385-390.
34. Bone R, Frank L, Springer JP, Pollack SJ, Osborne SA, Atack JR, Knowles MR,
McAllister G, Ragan CI, Broughton HB, et al: Structural analysis of inositol
monophosphatase complexes with substrates. Biochemistry 1994,
33(32):9460-9467.
35. Cole ST, Brosch R, Parkhill J, Garnier T, Churcher C, Harris D, Gordon SV,
Eiglmeier K, Gas S, Barry CE, textitet al: Decipheringthe biology of
Movahedzadeh et al. BMC Microbiology 2010, 10:50
http://www.biomedcentral.com/1471-2180/10/50
Page 14 of 15Mycobacterium tuberculosis from the complete genome sequence. Nature
1998, 393(6685):537-544.
36. Yano R, Nagai H, Shiba K, Yura T: A mutation that enhances synthesis of
sigma 32 and suppresses temperature-sensitive growth of the rpoH15
mutant of Escherichia coli. J Bacteriol 1990, 172(4):2124-2130.
37. Shiba K, Ito K, Yura T: Suppressors of the secY24 mutation: identification
and characterization of additional ssy genes in Escherichia coli. J Bacteriol
1986, 166(3):849-856.
38. Chang SF, Ng D, Baird L, Georgopoulos C: Analysis of an Escherichia coli
dnaB temperature-sensitive insertion mutation and its cold-sensitive
extragenic suppressor. J Biol Chem 1991, 266(6):3654-3660.
39. Inada T, Nakamura Y: Lethal double-stranded RNA processing activity of
ribonuclease III in the absence of suhB protein of Escherichia coli.
Biochimie 1995, 77(4):294-302.
40. Chen L, Roberts MF: Overexpression, purification, and analysis of
complementation behavior of E. coli SuhB protein: comparison with
bacterial and archaeal inositol monophosphatases. Biochemistry 2000,
39(14):4145-4153.
41. Nigou J, Dover LG, Besra GS: Purification and biochemical characterization
of Mycobacterium tuberculosis SuhB, an inositol monophosphatase
involved in inositol biosynthesis. Biochemistry 2002, 41:4392-4398.
42. Neuwald AF, Krishnan BR, Brikun I, Kulakauskas S, Suziedelis K, Tomcsanyi T,
Leyh TS, Berg DE: cysQ, a gene neededfor cysteine synthesis in
Escherichia coli K-12 only during aerobic growth. J Bacteriol 1992,
174(2):415-425.
43. Hofmann K, Bucher P, Falquet L, Bairoch A: The PROSITE database, its
status in 1999. Nucleic Acids Res 1999, 27(1):215-219.
44. Mailaender C, Reiling N, Engelhardt H, Bossmann S, Ehlers S, Niederweis M:
The MspA porin promotes growth and increases antibiotic susceptibility
of both Mycobacterium bovis BCG and Mycobacterium tuberculosis.
Microbiology 2004, 150(Pt 4):853-864.
45. Niederweis M, Ehrt S, Heinz C, Klocker U, Karosi S, Swiderek KM, Riley LW,
Benz R: Cloning of the mspA gene encoding a porin from
Mycobacterium smegmatis. Mol Microbiol 1999, 33(5):933-945.
46. Pollack SJ, Knowles MR, Atack JR, Broughton HB, Ragan CI, Osborne S,
McAllister G: Probing the role of metal ions in the mechanism of inositol
monophosphatase by site-directed mutagenesis. Eur J Biochem 1993,
217(1):281-287.
47. Sassetti CM, Boyd DH, Rubin EJ: Genes required for mycobacterial growth
defined by high density mutagenesis. Mol Microbiol 2003, 48(1):77-84.
48. Gu X, Chen M, Shen H, Jiang X, Huang Y, Wang H: Rv2131c gene product:
an unconventional enzyme that is both inositol monophosphatase and
fructose-1,6-bisphosphatase. Biochem Biophys Res Commun 2006,
339(3):897-904.
49. Hatzios SK, Iavarone AT, Bertozzi CR: Rv2131c from Mycobacterium
tuberculosis is a CysQ 3’-phosphoadenosine-5’-phosphatase. Biochemistry
2008, 47(21):5823-5831.
50. Muttucumaru DG, Roberts G, Hinds J, Stabler RA, Parish T: Gene expression
profile of Mycobacterium tuberculosis in a non-replicating state.
Tuberculosis (Edinb) 2004, 84(3-4):239-246.
51. Tamarit J, Mulliez E, Meier C, Trautwein A, Fontecave M: The anaerobic
ribonucleotide reductase from Escherichia coli. The small protein is an
activating enzyme containing a [4fe-4s](2+) center. J Biol Chem 1999,
274(44):31291-31296.
52. Sato T, Imanaka H, Rashid N, Fukui T, Atomi H, Imanaka T: Genetic
evidence identifying the true gluconeogenic fructose-1,6-bisphosphatase
in Thermococcus kodakaraensis and other hyperthermophiles. J Bacteriol
2004, 186(17):5799-5807.
53. Movahedzadeh F, Rison SC, Wheeler PR, Kendall SL, Larson TJ, Stoker NG:
The Mycobacterium tuberculosis Rv1099c gene encodes a GlpX-like
class II fructose 1,6-bisphosphatase. Microbiology 2004, 150(Pt
10):3499-3505.
54. Mahenthiralingam E, Marklund BI, Brooks LA, Smith DA, Bancroft GJ,
Stokes RW: Site-directed mutagenesis of the 19-kilodalton lipoprotein
antigen reveals No essential role for the protein in the growth and
virulence of Mycobacterium intracellulare. Infect Immun 1998,
66(8):3626-3634.
55. Gill R, Mohammed F, Badyal R, Coates L, Erskine P, Thompson D, Cooper J,
Gore M, Wood S: High-resolution structure of myo-inositol
monophosphatase, the putative target of lithium therapy. Acta Cryst
2005, D61:545-555.
doi:10.1186/1471-2180-10-50
Cite this article as: Movahedzadeh et al.: Inositol monophosphate
phosphatase genes of Mycobacterium tuberculosis. BMC Microbiology
2010 10:50.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Movahedzadeh et al. BMC Microbiology 2010, 10:50
http://www.biomedcentral.com/1471-2180/10/50
Page 15 of 15